ATE366107T1 - Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen - Google Patents

Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen

Info

Publication number
ATE366107T1
ATE366107T1 AT00974835T AT00974835T ATE366107T1 AT E366107 T1 ATE366107 T1 AT E366107T1 AT 00974835 T AT00974835 T AT 00974835T AT 00974835 T AT00974835 T AT 00974835T AT E366107 T1 ATE366107 T1 AT E366107T1
Authority
AT
Austria
Prior art keywords
inflammatory bowel
bowel disease
treat inflammatory
prophylaxis
treatment
Prior art date
Application number
AT00974835T
Other languages
English (en)
Inventor
Toru Kono
Masafumi Nomura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE366107T1 publication Critical patent/ATE366107T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00974835T 1999-11-11 2000-11-09 Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen ATE366107T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32105899 1999-11-11
JP2000225442 2000-07-26

Publications (1)

Publication Number Publication Date
ATE366107T1 true ATE366107T1 (de) 2007-07-15

Family

ID=26570344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974835T ATE366107T1 (de) 1999-11-11 2000-11-09 Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen

Country Status (16)

Country Link
US (3) US6730702B1 (de)
EP (1) EP1228758B1 (de)
KR (1) KR100526278B1 (de)
CN (1) CN100341497C (de)
AT (1) ATE366107T1 (de)
AU (1) AU773352B2 (de)
CA (1) CA2389032C (de)
CY (1) CY1106763T1 (de)
DE (1) DE60035429T2 (de)
DK (1) DK1228758T3 (de)
ES (1) ES2288878T3 (de)
MX (1) MXPA02004707A (de)
NZ (1) NZ518695A (de)
PT (1) PT1228758E (de)
TW (1) TW585762B (de)
WO (1) WO2001034143A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases
EP1380294A1 (de) * 2001-04-17 2004-01-14 Tanabe Seiyaku Co., Ltd. Mittel zur prävention/behandlung von entzündlichen erkrankungen der mundhöhlenschleimhaut und dergleichen
US6831101B2 (en) * 2001-06-14 2004-12-14 Chemokine Therapeutics Corporation Tricyclic rantes receptor ligands
CN1219757C (zh) * 2001-07-16 2005-09-21 中国医药研究开发中心有限公司 磺化去氢松香酸盐及其制备方法和其用途
MXPA04002868A (es) * 2001-09-27 2004-07-15 Tanabe Seiyaku Co Preparacion de solucion acuosa de ecabet sodico.
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
WO2004071453A2 (en) * 2003-02-13 2004-08-26 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of pouchitis
WO2005072113A2 (en) * 2004-01-20 2005-08-11 Harty Richard F Compositions and methods of treatment for inflammatory diseases
KR100802192B1 (ko) * 2004-07-27 2008-02-11 이병수 한약재를 이용한 발모제 조성물
EP2121048B9 (de) 2007-02-19 2016-02-24 Marine Polymer Technologies, Inc. Blutstillende zusammensetzungen und therapeutische verfahren dafür
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
KR100963051B1 (ko) 2008-03-14 2010-06-09 광동제약 주식회사 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물
CN101590031B (zh) * 2008-06-17 2011-10-12 浙江爱生药业有限公司 磺化去氢松香酸二钠组合物的制备方法
WO2011130646A1 (en) 2010-04-15 2011-10-20 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly -n-acetylglucosamine nanofibers
WO2012142581A1 (en) * 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acety glucosamine nanofibers
CN104447432B (zh) * 2014-11-21 2018-01-26 珠海亿邦制药股份有限公司 一种新的磺化去氢松香酸铋的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2107584A (en) 1981-10-22 1983-05-05 Tanabe Seiyaku Co Treatment of gastro-intestinal diseases
GB2114975B (en) * 1981-10-22 1985-06-05 Tanabe Seiyaku Co Salts of sulfodehydroabietic acid and treatment of gastro-intestinal diseases
JP3856908B2 (ja) 1997-06-06 2006-12-13 田辺製薬株式会社 褥瘡及び／又は創傷治療剤
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases

Also Published As

Publication number Publication date
KR20020050274A (ko) 2002-06-26
DE60035429D1 (de) 2007-08-16
CA2389032A1 (en) 2001-05-17
WO2001034143A1 (en) 2001-05-17
AU773352B2 (en) 2004-05-20
TW585762B (en) 2004-05-01
KR100526278B1 (ko) 2005-11-08
ES2288878T3 (es) 2008-02-01
CY1106763T1 (el) 2012-05-23
AU1302501A (en) 2001-06-06
EP1228758B1 (de) 2007-07-04
DK1228758T3 (da) 2007-10-29
US6730702B1 (en) 2004-05-04
CA2389032C (en) 2007-05-22
NZ518695A (en) 2003-10-31
US20040171686A1 (en) 2004-09-02
PT1228758E (pt) 2007-08-24
CN100341497C (zh) 2007-10-10
US20040254244A1 (en) 2004-12-16
MXPA02004707A (es) 2002-09-02
HK1045464A1 (en) 2002-11-29
EP1228758A1 (de) 2002-08-07
EP1228758A4 (de) 2004-04-21
DE60035429T2 (de) 2008-03-06
CN1414850A (zh) 2003-04-30
US7153886B2 (en) 2006-12-26

Similar Documents

Publication Publication Date Title
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
JO2371B1 (en) 4-phenyl-pyridine derivatives
MY130755A (en) Colchinol derivatives as vascular damaging agents
NO20071577L (no) Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
WO2005056524A3 (en) Therapeutic agents useful for treating pain
EA200601281A1 (ru) Азабензофуранзамещенные тиомочевины; ингибиторы репликации вирусов
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
WO2001039759A3 (en) Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
DE602004014791D1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
SE9901573D0 (sv) New compounds
ATE367387T1 (de) Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden
DE69927497D1 (de) Sulfonsäure- oder sulfonylamino-n-(heteroaralkyl)-azaheterozyklylamidverbindungen
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
SE0201837D0 (sv) Chemical compounds
SE9901572D0 (sv) New compounds
SE9903611D0 (sv) Novel compounds III
PT1218401E (pt) 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao
DE69930621D1 (de) Medizinische zusammensetzungen zur unmittelbaren freisetzung bei oraler anwendung
ATE447953T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis
DE60219680D1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1228758

Country of ref document: EP